Where is Nuuron's headquarters?

Nuuron is located in Berlin, Berlin, Germany.

Who invested in Nuuron?

Nuuron has 5 investors including IBB Ventures And HTGF (High-Tech Gruenderfonds).

When was the last funding round for Nuuron?

Nuuron closed its last funding round on obfuscated from a Seed round.

Who are Nuuron's competitors?

Alternatives and possible competitors to Nuuron may include Neuralink, Cognito Therapeutics, And Monteris Medical.

Nuuron - Growth Outlook

Growth Outlook

Growth Score

updated Jun 9, 2025

-4 pts

in past quarter

Growth Performance Over Time

Score

Trend

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

See more interactive data and historical milestones on desktop for the best experience

Growth Insight

See this Growth Insight

Nuuron is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Companies with Similar Growth

Organization Name	Growth Score	Industries	Headquarters Location	Description
Tempus	74	Artificial Intelligence (AI), Biotechnology, Health Care, Machine Learning, Medical, Oncology, Precision Medicine	Chicago, Illinois, United States	Tempus develops AI-enabled precision medicine technology that supports clinical decision-making and biomedical research.
Eli Lilly	76	Biotechnology, Health Care, Medical, Pharmaceutical	Indianapolis, Indiana, United States	Eli Lilly is a pharma company focused on developing medicines for diabetes, cancer, immunology, and other major health areas.
Insilico Medicine	68	Artificial Intelligence (AI), Biotechnology, Health Care, Pharmaceutical	Cambridge, Massachusetts, United States	Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.
BioAffinity Technologies	69	Biotechnology, Health Care, Life Science, Therapeutics	San Antonio, Texas, United States	BioAffinity Technologies is a cancer diagnostics company that develops non-invasive, early-stage diagnostics to detect cancer and diseases.
Freenome	73	Biotechnology, Health Care, Health Diagnostics, Oncology, Personal Health	South San Francisco, California, United States	Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.
DCVC Bio	75	AgTech, Biotechnology, Life Science, Venture Capital	San Francisco, California, United States	DCVC Bio is a venture capital fund that invests in early-stage life science companies driven by deep-tech approaches.
Secretome Therapeutics	72	Biotechnology, Health Care, Medical, Therapeutics	Dallas, Texas, United States	Secretome Therapeutics is a clinical-stage cell therapy company that develops therapies for rare cardiac diseases.
Waypoint Bio	70	Biotechnology, Computer Vision, Machine Learning	New York, New York, United States	Optimizing cell therapy with spatial biology
Caris Life Sciences	70	Artificial Intelligence (AI), Biopharma, Biotechnology, Health Care, Life Science, Oncology	Irving, Texas, United States	Caris Life Sciences develops molecular profiling and AI-driven technologies to support precision medicine in oncology.
XtalPi	71	Artificial Intelligence (AI), Biotechnology, Pharmaceutical	Shenzhen, Guangdong, China	XtalPi is a pharmaceutical technology company that is reinventing drug discovery by enabling dry lab predictions with wet lab validation.